Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1101/cshperspect.a025932 http://scihub22266oqcxt.onion/10.1101/cshperspect.a025932 C4772077!4772077!26931809     free     free     free       Cold+Spring+Harb+Perspect+Med 2016 ; 6 (3): ä Nephropedia Template TP {{tp|p=26931809|t=2016. Metformin: A Hopeful Promise in Aging Research |pdf=|usr=}}{{26931809}} gab.com Text Metformin: A Hopeful Promise in Aging Research JO: Cold Spring Harb Perspect Med http://www.kidney.de/pget.php?&tw=1&pmid=26931809 #FOAvip Even though the inevitable process of aging by itself cannot be considered a disease, it is directly linked to life span and is the driving force behind all age-related diseases. It is an undisputable fact that age-associated diseases are among the leading causes of death in the world, primarily in industrialized countries. During the last several years, an intensive search of antiaging treatments has led to the discovery of a variety of drugs that promote health span and/or life extension. The biguanide compound metformin is widely used for treating people with type 2 diabetes and appears to show protection against cancer, inflammation, and age-related pathologies. Here, we summarize the recent developments about metformin use in translational aging research and discuss its role as a potential geroprotector. Twit Text FOAVip Metformin: A Hopeful Promise in Aging Research ????Cold Spring Harb Perspect Med http://www.kidney.de/pget.php?&tw=1&pmid=26931809 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26931809 #FOAvip English Wikipedia <ref>{{Cite pmid|26931809}}</ref> Metformin: A Hopeful Promise in Aging Research #MMPMID26931809 Novelle MG; Ali A; Diéguez C; Bernier M; de Cabo R Cold Spring Harb Perspect Med 2016[Mar]; 6 (3): ä PMID26931809show ga Even though the inevitable process of aging by itself cannot be considered a disease, it is directly linked to life span and is the driving force behind all age-related diseases. It is an undisputable fact that age-associated diseases are among the leading causes of death in the world, primarily in industrialized countries. During the last several years, an intensive search of antiaging treatments has led to the discovery of a variety of drugs that promote health span and/or life extension. The biguanide compound metformin is widely used for treating people with type 2 diabetes and appears to show protection against cancer, inflammation, and age-related pathologies. Here, we summarize the recent developments about metformin use in translational aging research and discuss its role as a potential geroprotector. äMetformin: A Hopeful Promise in Aging Research (epmc).pdf DeepDyve Pubget Overpricing